RIBOMED BIOTECHNOLOGIES INC has a total of 31 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and environmental technology are BEIJING ENTRY EXIT INSPECTION & QUARANTINE BUREAU, BIOTECON DIAGNOSTICS GMBH and SHENZHEN KANGMEI BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Australia | 4 | |
#5 | China | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 1 | |
#9 | Norway | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Climate change adaptation technologies | |
#3 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Hanna Michelle M | 29 |
#2 | Mccarthy David | 10 |
#3 | David Mccarthy | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017117615A1 | ABORTIVE PROMOTER CASSETTES AND METHODS FOR FUSION TO TARGETS AND QUANTITATIVE CpG ISLAND METHYLATION DETECTION USING THE SAME | |
CN102421914A | Abscription based molecular detection | |
AU2004286265A1 | Compositions, methods and detection technologies for reiterative oligonucleotide synthesis | |
AU2004235368A1 | Molecular detection systems utilizing reiterative oligonucleotide synthesis | |
US7045319B2 | Molecular detection systems utilizing reiterative oligonucleotide synthesis |